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HOW STABLE ARE SOCIAL PREFERENCE
WEIGHTS FOR EQ-5D: RESULTS FROM A
PARTIAL REPLICATION STUDY
Macran S, Kind P
Outcomes Research Group,York, United Kingdom
In 1993 a national population survey was conducted in
the UK to determine social preference weights for EQ-5D
health states. The survey, conducted as part of the 
Measurement and Valuation of Health (MVH) Project
was based on face-to-face interviews with 3395 respon-
dents who used ranking, VAS rating and time trade-off
(TTO) methods to generate social preference weights. The
TTO weights derived from that survey are widely used 
in economic studies in which EQ-5D is used to measure
outcomes. OBJECTIVES: To test the stability of social
preference weights over time using a partial replication
protocol. METHODS: Face-to-face interviews were con-
ducted with 253 individuals randomly selected from elec-
toral registers in geographically convenient locations. The
protocol varied somewhat from the original MVH study
in that each respondent was asked to value a standard set
of 17 health states. Responses were weighted to achieve
matching with the age/gender mix of the MVH study.
Fieldwork was conducted in 1998. RESULTS: The rank
order of health states was highly similar in the two
surveys. VAS ratings were well approximated in the repli-
cation survey. TTO weights were higher in the second
survey, with fewer states being valued as worse than dead.
The median absolute difference in TTO preference
weights was 0.080. An OLS model used to interpolate
values for unobserved EQ-5D health states yielded 
lower parameter estimates for the extreme levels on 
each dimension in the 1998 data. CONCLUSIONS:
Social preference weights can and do vary over time. An
apparent shift in the value of dead relative to EQ-5D
health states may account for a reduction in the number
of states assigned a negative weight. Although the
absolute value of outcomes may depend upon which set
of weights is used, marginal differences in outcome may
remain unaffected.
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OBJECTIVE: To develop a preference-based index for
(post-) menopausal health, the latter including typical
menopausal symptoms as well as potential side-effects of
their causal treatment, i.e. hormone replacement therapy
(HRT). METHODS: The study had three phases: 1) the
development of a health state classiﬁcation system; 2) a
valuation survey; and 3) the estimation of a model for
valuing all states deﬁned by the system. A menopausal
health state classiﬁcation system with the seven dimen-
sions (QPI-7D) was developed, including hot ﬂushes,
aching joints or muscles, anxious or frightened feelings,
breast tenderness, bleeding, vaginal dryness and undesir-
able androgenic signs. Each dimension contains between
3 and 5 levels and deﬁnes a total of 6075 health states.
A sample of 96 health states was selected for empirical
valuation. These states were valued by a sample of 229
women aged 45 to 60 (37% postmenopausal, 33% on
HRT), randomly selected from 6 general practice lists in
Shefﬁeld, UK. Respondents were asked to complete a time
trade-off (TTO) task for 9 health states (their own plus
8 described states), resulting in an average of 16.5 values
for each health state. RESULTS: Mean health state values
ranged from 0.48 to 0.98. Own health was valued at 0.91
(mean). An additive random effects model of reasonable
ﬁt could be speciﬁed. Decrements for each level of symp-
toms reaching statistical signiﬁcance were estimated. The
general order of decrements (from highest to lowest) is:
aching joints and muscles, bleeding, breast tenderness,
anxious or frightened feelings, vaginal dryness, and
androgenic signs. While “hot ﬂushes” did reach statisti-
cal signiﬁcance in the current HRT user/past sufferer sub-
sample, it did not enhance model ﬁt in the overall sample.
CONCLUSION: This model provides a methodologically
sound and credible algorithm for valuing menopausal
health on the basis of the underlying health state classiﬁ-
cation system, the QPI-7D.
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ACARBOSE FOR THE PREVENTION OF TYPE II
DIABETES IN CANADA: AN ECONOMIC
EVALUATION
Getsios D1, Caro JJ2, Caro I3, Klittich W2, O’Brien JA2
1Caro Research Institute, Hammonds Plains, NS, Canada;
2Caro Research Institute, Concord, MA, USA; 3Caro Research
Institute, Dorval, QC, Canada
OBJECTIVE: To evaluate the cost-effectiveness of acar-
bose for the prevention of type II diabetes in Canadian
patients with impaired glucose tolerance (IGT) compared
to no treatment, metformin, and lifestyle modiﬁcation.
METHODS: A Markov model was developed to estimate
outcomes for patients with IGT. Patients could revert 
to normal glucose tolerance, remain with IGT, develop
diabetes, or die. Baseline transition probabilities were
derived from the STOP-NIDDM study, a placebo-
controlled trial of acarbose for the prevention of type II
diabetes in IGT, and supplemented with data from other
published trials. Direct costs were estimated for Ontario,
in 2000 Canadian dollars. Patients were assumed to
receive therapy for 5 years, and transitions were modeled
over 10 years. Sensitivity analyses covered all inputs.
Costs and outcomes were discounted at 5% per annum.
RESULTS: Over a decade, 542 out of 1000 patients are
expected to develop diabetes in the absence of an active
